-
A ‘Revolution’ in Cancer Research
AACR patient advocate forum explores how new clinical trial designs are accelerating drug testing.
by Thomas Celona
-
Finding Your Niche
Support groups offer community for people with cancer in a world that doesn’t understand their experience.
by Carly Flumer
-
Making Informed Consent Accessible
Confusing informed consent forms are a common barrier to clinical trial participation. Researchers ask how they can be better designed for patients.
by Sandra Gordon
-
Keep That Colonoscopy Appointment
Experts weigh in on a recent study appearing to show that colonoscopy had lower-than-expected efficacy for preventing colorectal cancer.
by Pamela Rafalow Grossman
-
What We Know About Ultraprocessed Foods and Cancer Risk
Research has linked highly processed foods like deli meat to a higher risk of colorectal cancer in men.
by Jon Kelvey
-
Patient and Doctor Partnerships
As more cancer patients take an interest in the science of their care, it’s vital to establish good relationships with doctors.
by Karon Warren
-
Exploring a New Frontier
AACR patient advocate forum addresses developments in cancer early detection tests.
by Thomas Celona
-
Forward Look
A New Breast Cancer SubtypeClinical trial results are changing care for people with metastatic breast cancer that expresses low levels of HER2 protein.
by Kris Conner
-
Cancer and Alcohol
Lowering and increasing alcohol consumption is associated with changes in cancer risk.
by Teresa Bergen
-
Grapefruit: The Healthy Fruit With a Potentially Dangerous Downside
The health benefits of grapefruit are well known, but cancer patients should be aware of potentially harmful interactions it can have with common medicines.
by Anne Danahy
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff